Hjem › Schizofreni › Arkansas
Kliniske studier for Schizofreni i Arkansas
21 studier for Schizofreni søker deltakere på steder i Arkansas.
Byer i Arkansas
Offisiell studietekst (engelsk)
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Vanda Investigational Site, Little Rock
RekruttererFase 4
Alder 12 til 17 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT05648591Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Pillar Clinical Research - Bentonville, Bentonville
- Pillar Clinical Research- Little Rock, Little Rock
- Local Institution - 0021, Little Rock
- og 1 flere
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07686263Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Pillar Clinical Research, LLC, Little Rock
RekruttererFase 3
Alder 5 til 17 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06229210NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Little Rock
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07105098NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Bryant
- Neurocrine Clinical Site, Little Rock
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07114874Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
- TG Therapeutics Investigational Trial Site, Little Rock
RekruttererFase 2
Alder 18 til 60 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07680946A Study of Brenipatide in Adult Participants With Schizophrenia
- Pillar Clinical Research- Little Rock, Little Rock
RekruttererFase 2
Alder 18 til 55 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07410507A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Bryant
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- Pillar Clinical Research, LLC, Little Rock
RekruttererFase 1
Alder 18 til 55 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07734493A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
- Woodland International Research Group /ID# 275747, Little Rock
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT0714591852-week Open Label Safety-Tolerability Study
- Pillar Clinical Research, Bentonville
- Pillar Clinical Research, Little Rock
- Woodland International Research Group, Little Rock
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07369154A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Little Rock
- Clinical Site, Little Rock
- Clinical Site, Rogers
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT07459647Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- SanRo Clinical Research Group, Bryant
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT07379827Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, Little Rock
RekruttererFase 3
Alder 10 til 17 · Alle kjønn · Oppdatert 14. aug. 2026 · NCT05303064Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
- Pillar Clinical Research LLC, Bentonville
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 29. jul. 2026 · NCT07467993Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
- Pillar Clinical Research, Bentonville
- Pillar Clinical Research, Little Rock
- Woodland International Research Group, Little Rock
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 27. jul. 2026 · NCT07363577A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Woodland International Research Group, Little Rock
RekruttererFase 2
Alder 18 til 55 · Alle kjønn · Oppdatert 23. jun. 2026 · NCT07191483A Study to Evaluate the Effect of KarXT on Urological Safety
- Pillar Clinical Research- Little Rock, Little Rock
RekruttererFase 4
Alder 18 til 65 · Alle kjønn · Oppdatert 3. jun. 2026 · NCT07221877NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Bryant
- Neurocrine Clinical Site, Little Rock
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 6. mar. 2026 · NCT06963034Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Rogers
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 12. jan. 2026 · NCT06961968Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Bentonville
- Reviva site, Little Rock
- Reviva site, Rogers
RekruttererFase 3Frivillige helsepersonell ønskes velkommen
Alder 18 til 65 · Alle kjønn · Oppdatert 19. des. 2024 · NCT05184335Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.